Free Delivery Over $100
|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Daniele FocosiPublisher: Springer Nature Switzerland AG Imprint: Springer Nature Switzerland AG Edition: 1st ed. 2021 Weight: 0.244kg ISBN: 9783030873233ISBN 10: 3030873234 Pages: 136 Publication Date: 12 October 2021 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand  We will order this item for you from a manufactured on demand supplier. Table of ContentsChapter 1. Why the Spike protein is relevant for COVID19 therapeutics.- Chapter 2. SARS-CoV-2 variants.- Chapter 3. Conclusion.ReviewsAuthor InformationDr. Daniele Focosi was born in Lucca (Italy) in 1980. He graduated in medicine with full grades in 2005 at the University of Pisa and completed specialization in hematology in 2009. Furthermore, he achieved a Ph.D. degree in clinical and fundamental virology in 2014 and a master’s degree in clinical trials in oncology-hematology in 2014. Dr. Focosi has authored over 150 peer-reviewed manuscripts indexed on PubMed, for a total h-index of 30. He has been a fellow of the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Trieste and of the Collegio Ghislieri in Pavia, Italy. He is currently employed full time at the Pisa University Hospital. He has given numerous oral and poster presentations at international medical congresses and is Member of the editorial board of 17 peer-reviewed journals. He has received awards from the European Federation of Immunogenetics, the European Society for Organ Transplantation, the Italian Society for Hematology, the Italian Interregional Transplant Association, the Italian Bone Marrow Donor Association, the Italian Society for Experimental Hematology, and the Italian Society against Leukemia/Lymphoma/Myeloma. Tab Content 6Author Website:Countries AvailableAll regions |
||||
